Archives for November 24, 2023

← 2023

Progress for Johnson & Johnson's lung cancer drug as extension submitted to EMA

24-Nov-2023

By Liza Laws

The Janssen Pharmaceutical Companies of Johnson & Johnson announced last week (November 23) the submission of a type 2 extension of indication application to the European Medicines Agency (EMA).

Calliditas Therapeutics' partner Everest Medicines' announces kidney drug approval

24-Nov-2023

By Liza Laws

Calliditas Therapeutics AB announced today (November 24) that its partner Everest Medicines has revealed that China's National Medical Products Administration (NMPA) has approved Nefecon.